Amphetamine - a pharmacological and clinical perspective

As reported in the Journal of Psychopharmacology, amphetamine has been recognized as an effective remedy for Attention Deficit Hyperactivity Disorder (ADHD) and other central nervous system ailments, including narcolepsy. Despite its widespread utilization in the United States, its application in Europe has been comparatively restrained. During World War II, various forms of amphetamines gained popularity for promoting wakefulness, leading to a substantial surge in production. That was a reason this medication found its way into the illicit market, contributing to the acknowledgment of amphetamine abuse in the 1950s.
The principal function of amphetamine is to elevate synaptic concentrations of monoamine neurotransmitters, thereby indirectly augmenting noradrenergic and dopaminergic neurotransmission in the central nervous system. Employed clinically to combat fatigue, serve as an appetite suppressant, and treat narcolepsy, amphetamine usage is associated with anticipated adverse effects such as anorexia, weight loss, and insomnia. It is common knowledge that individuals engaged in recreational drug use or dependency often administer psychostimulants at doses significantly exceeding those recommended for therapeutic purposes. Additionally, to achieve its optimal pharmacological impact, the maximum quantity of the drug must swiftly reach the central nervous system.